Cyclo Therapeutics, Inc.
CYTH
$0.7206
$0.00991.39%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -27.86% | -9.90% | -9.65% | -29.81% | -46.24% |
| Total Depreciation and Amortization | -40.93% | -28.57% | -14.87% | -1.03% | 3.21% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 439.31% | 248.58% | 108.53% | 116.27% | 1,239.74% |
| Change in Net Operating Assets | -125.17% | -87.23% | -84.11% | 6,455.19% | 331.63% |
| Cash from Operations | -53.84% | -33.31% | -22.81% | -7.08% | 2.28% |
| Capital Expenditure | -- | 77.14% | 77.14% | 84.11% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Investing | -- | -113.11% | -108.30% | -106.28% | -100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -68.61% | 86.77% | 709.13% | -- | -14.31% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 199.86% | 199.91% | 285.61% | 78,838.26% | 19,480.54% |
| Cash from Financing | 78.18% | 160.93% | 436.60% | 351,233.82% | 12.70% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 64.88% | 104.24% | 119.11% | 151.12% | 40.06% |
